Net profit of Medicamen Biotech declined 67.70% to Rs 1.35 crore in the quarter ended June 2024 as against Rs 4.18 crore during the previous quarter ended June 2023. Sales rose 2.65% to Rs 43.05 crore in the quarter ended June 2024 as against Rs 41.94 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 43.05 | 41.94 | 3 |
| OPM % | 7.99 | 16.57 | - |
| PBDT | 3.33 | 6.37 | -48 |
| PBT | 1.56 | 4.68 | -67 |
| NP | 1.35 | 4.18 | -68 |